Assessment of the Rehabilitative Effects of Curved-walking Training in Stroke, Parkinson and Orthopaedic Populations

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorIstituti Clinici Scientifici Maugeri SpA

About this trial

The recovery of walking ability is crucial to promote independence in daily living and is one of the major goal of neuromotor rehabilitation.

Currently, standard rehabilitative programs are usually based on straight-walking training (SWT) and the assessment of their effects is performed through functional scales based on straight-walking trajectories, e.g. Timed Up and Go (TUG), 10 meters walking test (10mWT).

Curved-walking training (CWT) may be interesting to provide an ecological and challenging context during rehabilitation. Indeed, CWT is based on demanding neural processes that drive an asymmetrical contribution at lower limb level, challenging balance ability and complex adaptation such as body weight shifting in response to centrifugal force and production of different step lengths.

Up to now, literature has investigated CWT in healthy adults in terms of muscular activation, kinematics and kinetics of the movement. Results showed that CWT needs a different biomechanical strategy with respect to SWT. Nevertheless CWT has not been investigated in pathological adults.

The present study aims at assessing the effectiveness of a rehabilitative physical therapy based on CWT with respect to traditional SWT for the recovery of locomotor abilities in neurological and orthopaedic patients.

The hypothesis is that a training based on curved-walking is ecologically meaningful and may be superior with respect to standard training in improving balance, walking abilities, and independence in activity of daily live of patients.

A secondary aim of the project is to propose an innovative functional scale based on the timed up and go on curved trajectory (CTUG), and to determine its reliability and responsiveness, establishing the minimum Detectable Change (MDC) and the Minimal Clinically Important Difference (MCID).

A single-blind randomized controlled study is being carried out on three different populations:

* Post-acute stroke patients * Idiopathic Parkinson Disease * Femoral fracture

A healthy group is also being recruited to provide reference values of CTUG. For each of the three populations, subjects are randomized into two groups. The experimental one performs a novel rehabilitative program composed by a 30-minute training on curved trajectory ("S" trajectory composed by two semicircle with a radius of 1.2 m) in addition to usual care. The control group performs an equal dose of traditional treatment on straight trajectories.

Both groups undergo 20 90-minutes sessions of training (three times a week for seven weeks).

Participants are evaluated at baseline (T0), after training (T1), and at a three-months follow-up visit (T2).

The primary outcome measure is the 10mWT (minimal clinically important difference of 0.16 m/s identified by Tilson and colleagues). On the basis of this measure, a sample size of 70 subjects for each population was computed.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Post-acute stroke patients experiencing a stroke less than 6 months before recruitment

Idiopathic Parkinson Disease with disability level from moderate to severe (modified Hoehn & Yahr scale 2.5-4)

Femoral fracture, less than 1 month form surgery

Disqualifiers

Cognitive deficits (Mini Mental Scale Evaluation < 24)

Hemineglect

Modified Ashworth Scale of lower limb >2

Unstable pharmacological treatment for Parkinson's Disease during the 15 days before the recruitment

Trial design

Design model

Parallel

Treatments tested in this trial

  • Novel locomotion treatment: curved-walking training

    Other intervention

    Each training session is comprehensive of a 30-minute walking training on curved trajectory ("S" trajectory composed by two semicircle with a radius of 1.2 m)

  • Standard locomotion treatment: straight-walking training

    Other intervention

    It consists of 30 minutes of locomotion training on straight trajectories, as typically proposed during traditional gait rehabilitation

  • Standard physical therapy

    Other intervention

    It consists of 60 minutes of stretching, muscular conditioning and coordination,postural exercises for trunk control, standing, functional exercies and upper limb rehabilitation, customized on patient's need.

Treatment groups

210 Participants
are divided into 2 treatment groups
Group A: Novel treatment, curved-walking trainingExperimental treatment 2 interventions
Group B: Usual careActive comparator 2 interventions

Trial outcomes

Primary outcomes

1

Change in 10 meter walk test (10MWT)

Time (seconds) needed by patients to walk for 10 meters

Time frame
Baseline, 7 weeks, 20 weeks

Secondary outcomes

1

curved-walking test

Time (seconds) needed to complete the "S" curved trajectory (7.53 m)

Time frame
Baseline, 7 weeks, 20 weeks
2

Timed Up and Go (TUG)

Time (seconds) needed to the patient to stand up upon therapist's command, walk 3 meters, turn around, walk back to the chair and sit down.

Time frame
Baseline, 7 weeks, 20 weeks
3

Curved Timed Up and Go

Time (seconds) needed to the patient to stand up upon therapist's command, walk 3 meters following the curved trajectory, turn around, walk back on the curved trajectory to the chair and sit down.

Time frame
Baseline (test), day 2 (retest), 7 weeks, 20 weeks
4

Balance test

Balance performance assessed by Balance test. Postural stability is evaluated using the commercial balance board Balance Master basicTM, NeuroCom® International, Inc. Assessments evaluate the postural sways during upright stance both with eyes open and closed; the limits of stability in different directions (forward, backward, right, and left); and the capability to shift the weight both left/right and forward/backward.

Time frame
Baseline, 7 weeks, 20 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Istituti Clinici Scientifici Maugeri SpA

Lead sponsor

Dept. of Electronics, Informatics, Bioengineering, Politecnico di Milano, Italy

Collaborator